| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
12,038 |
11,106 |
$4.10M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
20,214 |
18,745 |
$3.65M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,749 |
15,029 |
$1.84M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,394 |
11,317 |
$1.10M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,082 |
4,865 |
$784K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
12,732 |
11,136 |
$508K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,185 |
3,043 |
$295K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
11,883 |
9,987 |
$295K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,956 |
3,758 |
$290K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
12,193 |
2,550 |
$286K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
10,153 |
8,866 |
$271K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,712 |
3,648 |
$256K |
| 71045 |
Radiologic examination, chest; single view |
7,602 |
7,144 |
$250K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,221 |
2,909 |
$239K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,175 |
3,097 |
$221K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
360 |
333 |
$205K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,906 |
1,838 |
$200K |
| 71046 |
Radiologic examination, chest; 2 views |
4,377 |
4,200 |
$149K |
| 82947 |
|
4,958 |
2,955 |
$137K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
397 |
385 |
$123K |
| 80061 |
Lipid panel |
7,243 |
7,137 |
$108K |
| G0378 |
Hospital observation service, per hour |
2,887 |
2,538 |
$98K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
180 |
179 |
$89K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,686 |
1,637 |
$86K |
| 76830 |
Ultrasound, transvaginal |
1,498 |
1,459 |
$83K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,743 |
1,733 |
$82K |
| 93975 |
|
661 |
618 |
$72K |
| 59025 |
Fetal non-stress test |
830 |
497 |
$68K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
875 |
847 |
$65K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,512 |
2,360 |
$59K |
| 64635 |
|
68 |
65 |
$54K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
4,583 |
1,088 |
$54K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
740 |
726 |
$43K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
280 |
272 |
$43K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
96 |
86 |
$41K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
412 |
401 |
$39K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,616 |
1,254 |
$38K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,041 |
1,000 |
$35K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
266 |
119 |
$35K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
199 |
199 |
$34K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,498 |
416 |
$33K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
669 |
651 |
$33K |
| 76801 |
|
496 |
440 |
$27K |
| 97161 |
|
522 |
505 |
$27K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
39 |
38 |
$25K |
| 93971 |
|
386 |
372 |
$20K |
| 72110 |
|
720 |
705 |
$18K |
| 80053 |
Comprehensive metabolic panel |
36,824 |
32,514 |
$15K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,628 |
9,393 |
$15K |
| 73564 |
|
1,145 |
1,022 |
$13K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
985 |
985 |
$12K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,577 |
6,197 |
$12K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
91 |
90 |
$12K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
37,656 |
32,337 |
$12K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,006 |
975 |
$11K |
| 73030 |
|
1,148 |
1,067 |
$11K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
475 |
462 |
$9K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
240 |
53 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,177 |
1,118 |
$9K |
| 73610 |
|
1,163 |
1,087 |
$9K |
| 62323 |
|
30 |
29 |
$9K |
| 73630 |
|
1,404 |
1,325 |
$9K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
458 |
133 |
$8K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,620 |
8,630 |
$8K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,205 |
2,189 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,846 |
7,904 |
$7K |
| 71250 |
|
136 |
134 |
$6K |
| 94762 |
|
107 |
106 |
$6K |
| 73130 |
|
953 |
861 |
$6K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
199 |
197 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,153 |
5,090 |
$5K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
738 |
726 |
$5K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
700 |
688 |
$5K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
123 |
120 |
$5K |
| 97014 |
|
675 |
157 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
29,881 |
26,688 |
$4K |
| 94060 |
|
64 |
56 |
$4K |
| 95816 |
|
42 |
42 |
$4K |
| 72131 |
|
127 |
125 |
$4K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
553 |
549 |
$4K |
| 82728 |
|
2,800 |
2,758 |
$4K |
| 74018 |
|
229 |
207 |
$4K |
| 20610 |
|
27 |
27 |
$4K |
| 86900 |
|
1,399 |
1,349 |
$4K |
| 73502 |
|
306 |
295 |
$3K |
| 84439 |
|
3,280 |
3,239 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,303 |
6,925 |
$3K |
| 82607 |
|
2,931 |
2,897 |
$3K |
| 76775 |
|
81 |
80 |
$3K |
| 82746 |
|
2,514 |
2,487 |
$3K |
| 82670 |
|
457 |
456 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,124 |
1,981 |
$3K |
| 84403 |
|
553 |
549 |
$3K |
| 90670 |
|
16 |
15 |
$3K |
| 83550 |
|
2,890 |
2,851 |
$2K |
| 71271 |
|
38 |
38 |
$2K |
| 97162 |
|
67 |
58 |
$2K |
| 73110 |
|
374 |
339 |
$2K |
| 83001 |
|
528 |
527 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,940 |
4,075 |
$2K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
381 |
381 |
$2K |
| 83540 |
|
3,162 |
3,108 |
$2K |
| 84146 |
|
442 |
442 |
$2K |
| 94799 |
|
4,544 |
3,650 |
$2K |
| 83735 |
|
9,931 |
8,692 |
$2K |
| G0008 |
Administration of influenza virus vaccine |
125 |
125 |
$2K |
| 84144 |
|
329 |
329 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
8,837 |
7,311 |
$2K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
358 |
322 |
$2K |
| 83880 |
|
2,931 |
2,742 |
$2K |
| 84702 |
|
1,778 |
1,570 |
$1K |
| 76642 |
|
38 |
36 |
$1K |
| 83516 |
|
184 |
176 |
$1K |
| 70486 |
|
49 |
49 |
$1K |
| 72141 |
|
12 |
12 |
$1K |
| 85610 |
|
12,199 |
10,850 |
$1K |
| 76536 |
|
24 |
24 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,412 |
1,672 |
$1K |
| 87070 |
|
1,839 |
1,692 |
$1K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
69 |
69 |
$941.52 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,004 |
3,786 |
$935.22 |
| 72050 |
|
25 |
25 |
$921.53 |
| 86140 |
|
1,765 |
1,567 |
$885.41 |
| 72128 |
|
13 |
13 |
$868.99 |
| 87077 |
|
1,905 |
1,796 |
$783.38 |
| 99195 |
|
12 |
12 |
$777.48 |
| 82248 |
|
525 |
329 |
$770.81 |
| 72072 |
|
24 |
24 |
$764.39 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,904 |
1,835 |
$728.89 |
| 82627 |
|
142 |
142 |
$715.94 |
| 83690 |
|
8,721 |
8,005 |
$634.29 |
| 85027 |
|
2,311 |
2,144 |
$630.39 |
| 87186 |
|
1,667 |
1,565 |
$619.51 |
| 82247 |
|
356 |
219 |
$572.51 |
| 94760 |
|
3,854 |
3,113 |
$540.80 |
| 83655 |
|
311 |
311 |
$515.20 |
| 76770 |
|
12 |
12 |
$493.06 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
178 |
178 |
$488.53 |
| 85730 |
|
6,746 |
6,131 |
$476.03 |
| 81025 |
|
10,078 |
9,236 |
$473.64 |
| 96367 |
|
43 |
39 |
$411.71 |
| 85652 |
|
1,514 |
1,351 |
$411.13 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
440 |
342 |
$388.91 |
| 81001 |
|
8,588 |
7,985 |
$385.34 |
| 84481 |
|
317 |
312 |
$385.09 |
| 86850 |
|
1,084 |
1,041 |
$377.58 |
| 84100 |
|
2,851 |
2,628 |
$375.65 |
| 90686 |
|
31 |
29 |
$307.43 |
| 81003 |
|
7,304 |
6,876 |
$298.54 |
| 90656 |
|
15 |
15 |
$296.55 |
| 82150 |
|
582 |
565 |
$293.98 |
| 90688 |
|
13 |
13 |
$266.24 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
114 |
113 |
$261.83 |
| 87081 |
|
1,004 |
966 |
$251.83 |
| 97535 |
Self-care/home management training, each 15 minutes |
14 |
12 |
$242.65 |
| 80076 |
|
245 |
227 |
$242.26 |
| 74022 |
|
1,530 |
1,479 |
$234.28 |
| 73590 |
|
45 |
41 |
$221.34 |
| 82043 |
|
527 |
518 |
$214.22 |
| 82565 |
|
338 |
316 |
$212.18 |
| 73080 |
|
38 |
36 |
$196.48 |
| 93041 |
|
1,772 |
1,653 |
$190.19 |
| 82570 |
|
390 |
373 |
$184.21 |
| 72100 |
|
12 |
12 |
$171.90 |
| 80074 |
|
27 |
26 |
$165.58 |
| 86038 |
|
170 |
166 |
$143.48 |
| 83605 |
|
11,066 |
9,639 |
$139.71 |
| 84460 |
|
315 |
297 |
$135.30 |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
23 |
23 |
$135.00 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
16 |
12 |
$129.68 |
| 83615 |
|
202 |
190 |
$127.36 |
| 84550 |
|
292 |
271 |
$126.88 |
| 82626 |
|
14 |
14 |
$125.41 |
| 84450 |
|
244 |
228 |
$115.86 |
| 87808 |
|
24 |
24 |
$115.22 |
| 86901 |
|
1,679 |
1,599 |
$111.34 |
| 87205 |
|
771 |
700 |
$110.83 |
| 82550 |
|
1,259 |
1,143 |
$101.51 |
| 87075 |
|
346 |
308 |
$101.34 |
| 83721 |
|
60 |
57 |
$100.84 |
| 70496 |
|
13 |
13 |
$100.63 |
| G0237 |
Therapeutic procedures to increase strength or endurance of respiratory muscles, face to face, one on one, each 15 minutes (includes monitoring) |
15 |
12 |
$97.68 |
| 87040 |
|
3,278 |
2,423 |
$97.01 |
| 87634 |
|
488 |
470 |
$95.34 |
| 84484 |
|
10,533 |
6,841 |
$94.35 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,346 |
2,043 |
$85.50 |
| 92551 |
|
12 |
12 |
$83.16 |
| G0009 |
Administration of pneumococcal vaccine |
32 |
32 |
$80.52 |
| 84520 |
|
179 |
168 |
$77.15 |
| 82077 |
|
2,945 |
2,607 |
$70.74 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
54 |
54 |
$64.38 |
| 85018 |
|
667 |
644 |
$62.61 |
| 85379 |
|
2,298 |
2,209 |
$61.49 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
290 |
262 |
$57.04 |
| 87046 |
|
13 |
12 |
$35.04 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
303 |
261 |
$33.49 |
| A9270 |
Non-covered item or service |
17,094 |
7,640 |
$30.45 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,754 |
5,439 |
$24.82 |
| 84703 |
|
488 |
475 |
$24.26 |
| 80143 |
|
852 |
820 |
$23.17 |
| 80179 |
|
787 |
771 |
$23.17 |
| 87427 |
|
13 |
12 |
$22.23 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
281 |
275 |
$22.07 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
749 |
692 |
$22.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13,780 |
12,169 |
$19.84 |
| 82608 |
|
12 |
12 |
$17.99 |
| 87045 |
|
13 |
12 |
$17.52 |
| 86431 |
|
56 |
52 |
$15.52 |
| 88304 |
|
161 |
155 |
$14.81 |
| 86376 |
|
12 |
12 |
$8.20 |
| 81015 |
|
1,135 |
1,043 |
$6.35 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,461 |
1,340 |
$5.41 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
564 |
512 |
$4.11 |
| J3490 |
Unclassified drugs |
6,222 |
3,579 |
$3.30 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
899 |
834 |
$3.16 |
| 85014 |
|
42 |
40 |
$1.39 |
| C9113 |
Injection, pantoprazole sodium, per vial |
992 |
805 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
39 |
38 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
470 |
420 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,305 |
731 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
12,409 |
10,482 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,432 |
2,698 |
$0.00 |
| 90461 |
|
624 |
624 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,979 |
3,655 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
605 |
576 |
$0.00 |
| 90715 |
|
320 |
313 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,000 |
1,719 |
$0.00 |
| 77003 |
|
25 |
16 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
67 |
63 |
$0.00 |
| 29125 |
|
68 |
67 |
$0.00 |
| J2300 |
Injection, nalbuphine hydrochloride, per 10 mg |
16 |
12 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
28 |
28 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
132 |
123 |
$0.00 |
| 90681 |
|
15 |
14 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
34 |
24 |
$0.00 |
| 80305 |
|
309 |
281 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
26 |
26 |
$0.00 |
| 64636 |
|
17 |
15 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
50 |
32 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
137 |
124 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
12 |
12 |
$0.00 |
| 99173 |
|
12 |
12 |
$0.00 |
| 94664 |
|
53 |
26 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,819 |
1,541 |
$0.00 |
| 12001 |
|
133 |
132 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,121 |
1,723 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
5,097 |
4,589 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,045 |
1,779 |
$0.00 |
| 97010 |
|
2,566 |
591 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,807 |
1,334 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
461 |
457 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
1,801 |
1,732 |
$0.00 |
| 96376 |
|
2,630 |
1,924 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
744 |
734 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
552 |
524 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
633 |
604 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,651 |
1,478 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
5,734 |
5,081 |
$0.00 |
| 87449 |
|
65 |
60 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
1,392 |
1,148 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
46 |
44 |
$0.00 |
| 87390 |
|
12 |
12 |
$0.00 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
573 |
135 |
$0.00 |
| 90723 |
|
14 |
13 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
130 |
118 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
87 |
76 |
$0.00 |
| 86702 |
|
12 |
12 |
$0.00 |
| 87807 |
|
19 |
19 |
$0.00 |
| 72170 |
|
26 |
26 |
$0.00 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
76 |
73 |
$0.00 |
| 12002 |
|
14 |
13 |
$0.00 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
13 |
13 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
57 |
57 |
$0.00 |
| 86803 |
|
13 |
13 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
13 |
13 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
36 |
31 |
$0.00 |
| 86701 |
|
12 |
12 |
$0.00 |
| 96368 |
|
18 |
16 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
17 |
14 |
$0.00 |